Recent Finacing
Recent Raise
eFFECTOR Therapeutics is a clinical-stage biopharmaceutical company developing small-molecule selective translation regulators, advancing eIF4A and MNK1/2 inhibitors in oncology and evaluating antiviral activity, with Pfizer collaborations.
